We demonstrated that, in contrast to classical opioid receptors, ACKR3 doesn't cause classical G protein signaling and is not modulated because of the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. Rather, we set up that LIH383, an ACKR3-selective subnanomolar https://johne925hey4.theobloggers.com/profile